Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 821947, 9 pages
http://dx.doi.org/10.1155/2015/821947
Research Article

Fuyuan Decoction Enhances SOX9 and COL2A1 Expression and Smad2/3 Phosphorylation in IL-1β-Activated Chondrocytes

1Department of Combination of Chinese and Western Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
2College of Laboratory Medicine, Chongqing Medical University, Yuzhong District, Chongqing 400016, China
3Longgang District People’s Hospital of Shenzhen, Longgang District, Shenzhen, Guangdong 518172, China

Received 29 July 2015; Revised 16 November 2015; Accepted 17 November 2015

Academic Editor: Youn C. Kim

Copyright © 2015 Yudi Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Jia, G. Chen, G. Zhou, Y. Zhong, and R. Li, “Fuyuan Decoction inhibits nitric oxide production via inactivation of nuclear factor-κB in SW1353 chondrosarcoma cells,” Journal of Ethnopharmacology, vol. 146, no. 3, pp. 853–858, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Zhang, R. Li, S. Wang, X. Zhou, and Y. Zhong, “Study of molecular mechanisms of fuyuan capsule, icariin and arasaponin R1 in treatment of osteoarthritis,” Zhongguo Zhong Yao Za Zhi, vol. 36, no. 15, pp. 2113–2117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Zeng, W. Wang, X.-F. Rong et al., “Chondroprotective effects and multi-target mechanisms of Icariin in IL-1 β-induced human SW 1353 chondrosarcoma cells and a rat osteoarthritis model,” International Immunopharmacology, vol. 18, no. 1, pp. 175–181, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Niu, Z.-T. Sun, X.-W. Cao et al., “Regulation of single herb pilose antler on the expression of Smad2 and Smad3 in the cartilage of OA rats: an experimental research,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 34, no. 2, pp. 209–213, 2014. View at Google Scholar · View at Scopus
  5. H. J. Salminen, A.-M. K. Säämänen, M. N. Vankemmelbeke, P. K. Auho, M. P. Perälä, and E. I. Vuorio, “Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model,” Annals of the Rheumatic Diseases, vol. 61, no. 7, pp. 591–597, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Martel-Pelletier, “Pathophysiology of osteoarthritis,” Osteoarthritis and Cartilage, vol. 6, no. 6, pp. 374–376, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Wang, F. Zhu, N. H. Lee, and K. Konstantopoulos, “Shear-induced interleukin-6 synthesis in chondrocytes: roles of E prostanoid (EP) 2 and EP3 in cAMP/protein kinase A- and PI3-K/Akt-dependent NF-κB activation,” The Journal of Biological Chemistry, vol. 285, no. 32, pp. 24793–24804, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Chen, J. Xie, R. Rajappa, L. Deng, and J. Fredberg, “Interleukin-1β and tumor necrosis factor-α increase stiffness and impair contractile function of articular chondrocytes,” Acta Biochimica et Biophysica Sinica, vol. 47, no. 2, pp. 121–129, 2015. View at Publisher · View at Google Scholar
  9. J. A. Roman-Blas, D. G. Stokes, and S. A. Jimenez, “Modulation of TGF-β signaling by proinflammatory cytokines in articular chondrocytes,” Osteoarthritis and Cartilage, vol. 15, no. 12, pp. 1367–1377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. E. N. B. Davidson, P. M. van der Kraan, and W. B. van den Berg, “TGF-β and osteoarthritis,” Osteoarthritis and Cartilage, vol. 15, no. 6, pp. 597–604, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Song, K. D. Estrada, and K. M. Lyons, “Smad signaling in skeletal development and regeneration,” Cytokine and Growth Factor Reviews, vol. 20, no. 5-6, pp. 379–388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. P. M. van der Kraan, E. N. Blaney Davidson, A. Blom, and W. B. van den Berg, “TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads,” Osteoarthritis and Cartilage, vol. 17, no. 12, pp. 1539–1545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. B. Goldring, K. Tsuchimochi, and K. Ijiri, “The control of chondrogenesis,” Journal of Cellular Biochemistry, vol. 97, no. 1, pp. 33–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Onyekwelu, M. B. Goldring, and C. Hidaka, “Chondrogenesis, joint formation, and articular cartilage regeneration,” Journal of Cellular Biochemistry, vol. 107, no. 3, pp. 383–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Kawakami, J. Rodriguez-León, and J. C. I. Belmonte, “The role of TGFβs and Sox9 during limb chondrogenesis,” Current Opinion in Cell Biology, vol. 18, no. 6, pp. 723–729, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Quintana, N. I. Zur Nieden, and C. E. Semino, “Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering,” Tissue Engineering B: Reviews, vol. 15, no. 1, pp. 29–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. P. M. van der Kraan, E. N. Blaney Davidson, and W. B. van den Berg, “A role for age-related changes in TGFβ signaling in aberrant chondrocyte differentiation and osteoarthritis,” Arthritis Research and Therapy, vol. 12, no. 1, article 201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Yang, L. Chen, X. Xu, C. Li, C. Huang, and C.-X. Deng, “TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage,” The Journal of Cell Biology, vol. 153, no. 1, pp. 35–46, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Palmieri, D. Lodi, and S. Capone, “Osteoarthritis and degenerative joint disease: local treatment options update,” Acta Biomedica, vol. 81, no. 2, pp. 94–100, 2010. View at Google Scholar · View at Scopus
  20. R. Cheung, T.-T. Cheng, Y. Dong et al., “Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis,” International Journal of Rheumatic Diseases, vol. 13, no. 2, pp. 151–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Singh, N. Akhtar, and T. M. Haqqi, “Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected],” Life Sciences, vol. 86, no. 25-26, pp. 907–918, 2010. View at Publisher · View at Google Scholar
  22. S. E. Campbell, D. Bennett, L. Nasir, E. A. Gault, and D. J. Argyle, “Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model,” Rheumatology, vol. 44, no. 6, pp. 735–743, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Ketola, A.-M. Määttä, T. Pasanen, K. Tulimäki, and J. Wahlfors, “Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy,” International Journal of Molecular Medicine, vol. 13, no. 5, pp. 705–710, 2004. View at Google Scholar · View at Scopus
  24. A. M. Bhosale and J. B. Richardson, “Articular cartilage: structure, injuries and review of management,” British Medical Bulletin, vol. 87, no. 1, pp. 77–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. R. Eyre, “Collagens and cartilage matrix homeostasis,” Clinical Orthopaedics and Related Research, no. 427, supplement, pp. S118–S122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. D. R. Eyre, M. A. Weis, and J.-J. Wu, “Articular cartilage collagen: an irreplaceable framework?” European Cells and Materials, vol. 12, pp. 57–63, 2006. View at Google Scholar · View at Scopus
  27. D. Heinegård, “Proteoglycans and more—from molecules to biology,” International Journal of Experimental Pathology, vol. 90, no. 6, pp. 575–586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. D. M. Bell, K. K. H. Leung, S. C. Wheatley et al., “SOX9 directly regulates the type-II collagen gene,” Nature Genetics, vol. 16, no. 2, pp. 174–178, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. G. J. Inman, F. J. Nicolás, J. F. Callahan et al., “SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7,” Molecular Pharmacology, vol. 62, no. 1, pp. 65–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. E. N. Blaney Davidson, E. L. Vitters, P. M. van der Kraan, and W. B. van den Berg, “Expression of transforming growth factor-β (TGFβ) and the TGFβ signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: Role in cartilage degradation, chondrogenesis and osteophyte formation,” Annals of the Rheumatic Diseases, vol. 65, no. 11, pp. 1414–1421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. E. N. Blaney Davidson, A. Scharstuhl, E. L. Vitters, P. M. van der Kraan, and W. B. van den Berg, “Reduced transforming growth factor-beta signaling in cartilage of old mice: role in impaired repair capacity,” Arthritis Research & Therapy, vol. 7, no. 6, pp. R1338–1347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. Wu, J. H. Huang, E. R. Sampson et al., “Smurf2 induces degradation of GSK-3β and upregulates β-catenin in chondrocytes: a potential mechanism for Smurf2-induced degeneration of articular cartilage,” Experimental Cell Research, vol. 315, no. 14, pp. 2386–2398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C.-G. Li, Q.-Q. Liang, Q. Zhou et al., “A continuous observation of the degenerative process in the intervertebral disc of Smad3 gene knock-out mice,” Spine, vol. 34, no. 13, pp. 1363–1369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Hiroko, A. Sakae, and O. Yukio, “Effect of shosaikoto, a Japanese and Chinese traditional herbal medicinal mixture, on the mitogenic activity of lipopolysaccharide: a new pharmacological testing method,” Journal of Ethnopharmacology, vol. 21, no. 1, pp. 45–53, 1987. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Bochu, Z. Liancai, and C. Qi, “Primary study on the application of Serum Pharmacology in Chinese traditional medicine,” Colloids and Surfaces B: Biointerfaces, vol. 43, no. 3-4, pp. 194–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. J. A. Roman-Blas, M. A. Contreras-Blasco, R. Largo, M. A. Álvarez-Soria, S. Castañeda, and G. Herrero-Beaumont, “Differential effects of the antioxidant n-acetylcysteine on the production of catabolic mediators in IL-1β-stimulated human osteoarthritic synoviocytes and chondrocytes,” European Journal of Pharmacology, vol. 623, no. 1–3, pp. 125–131, 2009. View at Publisher · View at Google Scholar · View at Scopus